BFM
BSX icon

Boothbay Fund Management’s Boston Scientific BSX Stock Holding History

Boothbay Fund Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.51M Buy
+71,800
New +$5.74M 0.06% 347
2022
Q4 		– Sell
-17,900
Closed -$693K – 2025
2022
Q3 		$693K Buy
+17,900
New +$718K 0.02% 1064
2022
Q1 		– Sell
-16,500
Closed -$701K – 2290
2021
Q4 		$701K Buy
+16,500
New +$693K 0.02% 890

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boothbay Fund Management's BSX Position: Q1 2026 in Review

Boothbay Fund Management increased its Boston Scientific (BSX) stake by 106% in Q1 2026, buying an estimated $3.1M and bringing the position to 75,212 shares worth $4.72M. The position accounts for 0.06% of the portfolio, ranked #336.

Boothbay Fund Management first reported a position in BSX in Q3 2015 and has held it in 30 quarters since. The position peaked at $16.6M in Q3 2022. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Boothbay Fund Management held 75,212 shares of Boston Scientific worth $4.72M as of Q1 2026.
  • Boothbay Fund Management bought 38,768 Boston Scientific shares in Q1 2026, an estimated $3.1M.
  • Boston Scientific made up 0.06% of Boothbay Fund Management's portfolio in Q1 2026, its #336 holding.
  • Boothbay Fund Management first reported a position in Boston Scientific in Q3 2015 and has held it in 30 quarters since.
  • Boothbay Fund Management's Boston Scientific position peaked at $16.6M in Q3 2022.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.